After previously reviewing the company’s standing in advance of their conference call, Capital 10X spoke with Bee Vectoring Technologies
This season represents the start of the company’s first commercial sales of its award-winning patented technology. We discuss what investors can expect in terms of revenue per acre, economics, and the total targeted market.
After recently closing two separate $1 million financings and announcing multiple commercial sales agreements – this story continues to be intriguing.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.